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Background: Vascular risk factors are associated with increased risk of cognitive impairment and dementia, but
their association with motor function, another key feature of aging, has received little research attention.We ex-
amined the association between trajectories of the Framingham general cardiovascular disease risk score (FRS)
over midlife and motor function later in life.
Methods: A total of 5376 participants of the Whitehall II cohort study (29% women) who had up to four repeat
measures of FRS between 1991–1993 (mean age = 48.6 years) and 2007–2009 (mean age = 65.4 years) and
without history of stroke or coronary heart disease in 2007–2009 were included. Motor function was assessed
in 2007–2009 through objective tests (walking speed, chair rises, balance, ﬁnger tapping, grip strength). We
used age- and sex-adjusted linear mixed models.
Results: Participants with poorer performances for walking speed, chair rises, and balance in 2007–2009 had
higher FRS concurrently and also in 1991–1993, on average 16 years earlier. These associations were robust to
adjustment for cognition, socio-economic status, height, and BMI, and not explained by incident mobility limita-
tion prior to motor assessment. No association was found with ﬁnger tapping and grip strength.
Conclusions: Cardiovascular risk early inmidlife is associatedwith poormotor performances later in life. Vascular
risk factors play an important and under-recognized role in motor function, independently of their impact on
cognition, and suggest that better control of vascular risk factors in midlife may prevent physical impairment
and disability in the elderly.© 2013 The Authors. Published by Elsevier Ireland Ltd. Open access under CC BY license. 1. Introduction
In addition to being strong predictors of cardio- and cerebrovascular
disease, vascular risk factors have been associated with aging pheno-
types, including worse cognitive function [1] and dementia [2]. Motor
impairment is another key aspect of the aging process and poor motor
function has been linked to adverse health outcomes, including disabil-
ity [3] and death [4]. However, the association of vascular risk factorsingham general cardiovascular
dy mass index; SD, standard
liability and freedom from bias
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land Ltd. Open access under CC BY licewith motor function has received little research attention. To date,
there is some evidence linking individual risk factors (hypertension
[5], diabetes [6]) or markers of subclinical atherosclerosis [7–9] to
poorer motor function, but the combined effect of vascular risk factors
remains unknown.
For better prediction of cardiovascular disease (CVD) risk and amore
complete assessment of vascular burden, several risk algorithms
encompassing multiple risk factors have been developed [10]. Scores
derived from these algorithms predict the risk of CVD, stroke, dementia
[11], and cognitive deﬁcit [12,13], but to our knowledge their associa-
tion with motor function has not been examined. Here, we examine
the association between trajectories of the Framingham general cardio-
vascular disease risk score (FRS) [14] during midlife, using four assess-
ments over 16 years, and motor function at the end of the follow-up.
2. Methods
2.1. Participants
TheWhitehall II study is a longitudinal study of 10,308 civil servants [15]. All civil ser-
vants aged 35–55 years in 20 London based departments were invited to participatense. 
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quent phases including clinical examinations and questionnaires were in 1991–1993,
1997–1999, 2002–2004, and 2007–2009. Participants gave written consent; the Universi-
ty College London ethics committee approved the study.
2.2. Motor function
Motor function was assessed in 2007–2009 throughmeasures of walking speed, chair
rises, balance, grip strength, and ﬁnger tapping; while the ﬁrst three tests involve several
systems and represent global measures, the last two are taken at the upper limbs and rep-
resent more speciﬁc measures (muscle strength, psychomotor speed). A practice session
was allowed for all. Correlations between tests were weak to moderate (supplementary
Table 1).
Walking speed was measured at usual pace over a marked 8-ft (2.44 m) course. The
starting position was standing at the start of the course. A trained nurse walked behind
the participant and stopped timing when the participant's foot hit the ﬂoor after the end
of the course. Three tests were conducted; walking speed was computed as 2.44 m divid-
ed by the mean of three measures (in seconds).
Time to complete 5 chair rises: participants sat on an armless chair with feet resting on
the ﬂoor and arms folded across their chest. They stood up without using their arms and
sat down ﬁve times as quickly as possible. Time needed to complete the ﬁve chair rises
was recorded. Participants (n = 6) not able to stand up ﬁve times were excluded.
Balance was assessed through a series of tests of varying difﬁculty (full- and semi-
tandem stands, one-leg balance with eyes open or closed). For the present analyses, we
used data from the full-tandem stand and one-leg balance test with eyes open. Partici-
pants were ﬁrst asked to perform a full-tandem stand (10 s). If they passed this test,
they proceeded to perform a one-leg balance test (30 s). Participants who failed either
test were deemed to have failed the balance test.
Grip strength (in kilograms; dominant hand)wasmeasuredusing a Smedley handgrip
dynamometer adjusted to suit participants' handswith participants seated, their elbow on
the table, forearm pointing upwards, and palm of the hand facing up. Participants were
asked to squeeze the dynamometer as hard as possible for 2 s. Three testswere performed
with a one minute rest between each. Readings were rounded up to the nearest whole
number; the mean of the tests was used.
Finger tapping test: the number of taps during 10 s was recorded using an electronic
device (WPS Electronic tapping test) [16] with participants holding their dominant hand
palm down, ﬁngers extended, keeping their hand and arm stationary, and tapping on
the lever using their index.
2.3. Framingham general cardiovascular disease risk score
The FRS was developed as part of the Framingham Heart study to assess general CVD
risk and risk of individual events (coronary, cerebrovascular, peripheral artery disease,
heart failure) [14]. It includes measures of age, HDL- and total cholesterol, systolic blood
pressure, cigarette smoking, and diabetes, and provides an estimate of the 10-year risk
of CVD.
Risk score componentswere drawn fromquestionnaires and clinical examination data
at four waves: 1991–1993, 1997–1999, 2002–2004, and 2007–2009. Total cholesterol
and HDL cholesterol (mg/dL) were measured from blood collected after either an 8 h
fast (participants presenting in the morning), or at least 4 h after a light fat-free breakfast
(participants presenting in the afternoon). Cholesterol was measured using a Cobas Fara
centrifugal analyzer (RocheDiagnostics System). HDL cholesterolwasmeasured by precip-
itating non-HDL cholesterol with dextran sulfate-magnesium chloride andmeasuring cho-
lesterol in the supernatantﬂuid. Systolic bloodpressure (mm Hg)was takenas the average
of twomeasurements in the sitting position after a 5 min rest with the Hawksley random-
zero sphygmomanometer. Treated hypertension was determined according to antihyper-
tensive medication use. Participants were categorized as current smokers, ex- or non-
smokers. Diabetes was deﬁned by fasting glucose ≥7.0 mmol/L, 2 h post-load glucose
≥11.1 mmol/L, doctor diagnosed diabetes, or use of diabetes medication [17].
2.4. Covariates
Individuals with prevalent or incident stroke or coronary heart disease (non-fatal
myocardial infarction, deﬁnite angina) between 1991–1993 and 2007–2009were exclud-
ed as these conditions are known to affectmotor performances. Myocardial infarctionwas
diagnosed based on clinical examination data, electrocardiograms, and medical records
[18]. Anginawas assessed based on reports of symptoms and nitratemedication,with cor-
roboration in medical records or abnormalities on a resting electrocardiogram, exercise
electrocardiogram, or coronary angiogram. Classiﬁcation was carried out independently
by two trained coders, with adjudication by a third party in the event of disagreement.
Stroke was self-reported and included history of stroke or transient ischemic attack.
At all waves,mobility limitationswere assessed using questions on the ability to climb
several ﬂights of stairs or walkmore than 1 mile. Socioeconomic status (SES)was deﬁned
based on the highest 3-level British civil service employment grade achieved (high, ad-
ministrative; intermediate, professional or executive; low, clerical or support). Weight
and height were measured and body mass index (BMI) was calculated as weight divided
by height squared (kg/m2). Cognitive statuswas assessed using the Alice Heim4-I (AH4-I)
test [19], which includes 65 verbal and mathematical reasoning items assessing inductive
reasoning by measuring the ability to identify patterns and infer principles and rules;
higher scores correspond to better function. Participants had 10 min to do this test.2.5. Statistical analysis
Descriptive analyses were carried out to examine participants' characteristics at each
wave and their association with motor tests and FRS in 2007–2009. Correlations between
z-scores of motor tests were examined through age- and sex-adjusted partial Spearman
correlations.
The association between the FRS and motor tests was examined separately for each
test to establish whether motor function was associated with FRS concurrently and with
FRS trajectories over 16 years prior to motor testing. We deﬁned age- and sex-speciﬁc
quartiles (supplementary Table 2) for all tests with continuous measures (walking
speed, grip strength,ﬁnger tapping, chair rises), given thatmotor performances decreased
with age (p b 10−4) and were higher in men than women (p b 10−4) [20]. For balance
(binary measure), models were age- and sex-adjusted.
We used linear mixed models that take into account correlations between repeated
measures on the same individual, with FRS as the dependent variable and quartiles of
motor tests as independent variables; this approach allows examining FRS trajectories
prior to the measurement of motor function (2007–2009) as well as their concurrent as-
sociation. FRS was logarithmically transformed due to its skewed distribution; results
were back-transformed for graphs. Models were implemented with a backward time
scale, so that 2007–2009 corresponds to the baseline (time = 0) and participants are
tracked back until 1991–1993, approximately 16 years earlier. Time was divided by 10,
so that regression coefﬁcients represent change in FRS over 10 years. Inspection of the
data showed that FRS change over time was not linear; we therefore included a quadratic
term for time. Both the intercept and slope (time)were ﬁtted as random effects. Themain
effect represents the mean FRS difference in 2007–2009 between the reference quartile
(best performance) and other quartiles. The interaction term between quartiles of motor
tests and time allows examiningwhether the association between FRS andmotor function
changed over time; non-linear differences in change were allowed by including interac-
tion terms between the quadratic time term and quartiles of motor tests.
Lower SES, weight, and height are strongly associated with motor performances and
FRS [21]. Poorer cognitive function is also associated with higher FRS [13] and worse
motor function [22,23]. We examinedwhether our ﬁndings were explained by confound-
ing (SES,weight, height) ormediated by cognition by including the following covariates in
models as main effects together with their signiﬁcant (p b 0.05) interactions with time:
SES (high vs intermediate/low), quartiles of BMI and height, the measure of cognition
(AH4-I). These analyses used time invariant covariates deﬁned in 2007–2009, and were
replicated using time-dependent covariates; they were adjusted for age in 2007–2009
and sex and their interactions with time (linear, squared).
In sensitivity analyses, we examined the inﬂuence of incidentmobility limitations be-
fore the assessment of motor function by excluding participants who reported mobility
limitations (limited to climb several ﬂights of stairs or to walk more than 1 mile) at
least once between 1991–1993 and 2002–2004.
As FRS is higher in men than women [13], and men perform better than women on
motor tests [20], we examinedwhether sexmodiﬁed cross-sectional associations between
the FRS and motor tests. We also investigated whether age modiﬁed their association.
Two-tailed p-values ≤0.05 were considered to be statistically signiﬁcant. Statistical
analyses were performed using SAS 9.2 (SAS Institute, Cary, North Carolina, USA).3. Results
Of 10,308 participants of Whitehall II at inception (1985–1988),
8104 participated in the clinical 1991–1993 examination, 954 died be-
fore 2007, and 6225 participated in the 2007–2009 clinical examina-
tion; compared to those who participated in 2007–2009, those who
did not were older (p b 0.001), more often women (p b 0.001), and
had higher FRS (p b 0.001) in 1991–1993. We excluded 725 partici-
pants with a history of CHD/stroke, and 124 participants who did not
have FRS or motor data. Our analyses are based on 5376 participants.
The chair rise test was missing for 7.2% of the participants due to more
stringent exclusion criteria than for other tests.
Participants' characteristics at fourwaves are shown in Table 1; 3250
(60%) participants had four FRS measurements, 1225 (23%) three, 633
(12%) two, and 268 (5%) one. Mean (SD) FRS increased from 8.6%
(6.3) in 1991–1993 to 16.9% (10.6) in 2007–2009 (on average
16.8 years later) with the prevalence of vascular risk factors, besides
smoking, also rising over this period. Higher age, male sex, and vascular
risk factors were strongly associated with higher cardiovascular risk
(Table 2); after adjustment for age and sex, higher BMI, smaller height,
lower SES, and worse cognitive function remained associated with
higher risk. Participants who developed mobility limitations between
1991–1993 and 2002–2004 had higher FRS than those who did not.
Geometric FRS means from 1991–1993 to 2007–2009 according to
quartiles of motor tests are presented in Table 3. Differences between
the top and bottom quartiles were larger for walking speed, chair
Table 1
Clinical characteristics of Whitehall II participants.
Characteristics Year
1991–1993 1997–1999 2002–2004 2007–2009
N = 4699a N = 3954a N = 4427a N = 5129a
Women, n (%) 1375 (29.3) 1104 (27.9) 1280 (28.9) 1475 (28.8)
Mean age (SD) 48.6 (5.8) 55.0 (5.8) 60.5 (5.8) 65.4 (5.8)
High grade, n (%) 2316 (49.3) 2011 (50.9) 2201 (49.7) 2527 (49.3)
Mean BMI (SD), kg/m2 25.0 (3.5) 25.8 (3.8) 26.5 (4.2) 26.6 (4.4)
Mean height (SD), cm 173 (9) 173 (9) 171 (9) 171 (9)
Mean SBP (SD), mm Hg 119 (13) 123 (16) 127 (16) 126 (16)
Mean DBP (SD), mm Hg 79 (9) 78 (10) 74 (10) 71 (10)
Antihypertensive drugs, n (%) 201 (4.3) 372 (9.4) 838 (18.9) 1576 (30.7)
Mean HDL cholesterol (SD), mmol/L 1.45 (0.41) 1.47 (0.39) 1.59 (0.44) 1.61 (0.45)
Mean total cholesterol (SD), mmol/L 6.38 (1.13) 5.92 (1.05) 5.78 (0.99) 5.30 (1.06)
Current smokers, n (%) 478 (10.2) 299 (7.6) 299 (6.7) 361 (7.0)
Diabetes, n (%) 95 (2.0) 155 (3.9) 313 (7.1) 564 (11.0)
Mean cognitive score (AH4-I) (SD)b 47 (10) 48 (10) 45 (11) 44 (11)
No mobility limitationc 3410 (72.6) 2652 (68.5) 2866 (65.6) 3069 (60.3)
Mean (geometric) FRS (SD), % 8.6 (6.3) 11.5 (7.9) 15.0 (9.7) 16.9 (10.6)
Mean walking speed (SD), m/s – – – 1.11 (0.27)d
Mean time for ﬁve chair rises (SD), s – – – 10.9 (3.3)d
Failed balance test, n (%) – – – 2238 (44.5)d
Mean number of taps per 10 s (ﬁnger tapping test) (SD) – – – 54.0 (10.8)d
Mean grip strength (SD), kg – – – 36.2 (10.4)d
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FRS, Framingham cardiovascular disease.
a Number of participants with the FRS at each examination.
b 1991–1993, N = 2100; 1997–1999, N = 3663; 2002–2004, N = 4357; 2007–2009, N = 5036.
c No difﬁculty to climb several ﬂights of stairs and to walk more than 1 mile.
d 5376 participants had at least onemotor test in 2007–2009 and at least one FRS during the follow-up. Missing values for motor tests: walking speed, N = 31; grip strength, N = 56;
FTT, N = 16; chair rises, N = 387; balance, N = 95.
98 A. Elbaz et al. / International Journal of Cardiology 172 (2014) 96–102rises, and balance than for grip strength and ﬁnger tapping, and these
differences increased somewhat over time. The results of modeling
FRS trajectories are presented in Table 4 and Fig. 1. There was good
agreement between observed (Table 3) and predicted differences
(Fig. 1) in FRS between top and bottom quartiles of motor tests. For
walking speed, chair rises, and balance, participants with poor perfor-
mances in 2007–2009 had higher FRS concurrently as well as in
1991–1993, on average 16 years earlier. The largest differences were
observed for walking speed, followed by balance, and ﬁnally chair
rises. After back-transformation of the log-FRS, differences in FRS across
groups tended to increase over time and be larger in 2007–2009 than in
1991–1993 (Fig. 1). FRS was not associated with measures taken at
upper limbs (grip strength, ﬁnger tapping) at any time point.Table 2
Correlates of the Framingham general cardiovascular risk score assessed in 2007–2009.
Characteristics Framingham general cardiovascular ri
b10% 10–14.9
N = 1446 N = 11
Women, % (95% CI) 74 (72–76) 25 (23–
Mean age (SE) 62.2 (0.1) 65.5 (0
High grade, % (95% CI) 51 (46–57) 50 (47–
Mean BMI (SE), kg/m2 24.7 (0.1) 26.9 (0
Mean height (SE), cm 168.7 (0.2) 167.8 (
Mean SBP (SE), mm Hg 112.4 (0.4) 125.4 (
Mean DBP (SE), mm Hg 64.4 (0.3) 71.2 (0
Antihypertensive drugs, % (95% CI) 12 (9–16) 25 (23–
Mean HDL cholesterol (SE), mmol/L 1.93 (0.01) 1.67 (0
Mean total cholesterol (SE), mmol/L 5.00 (0.03) 5.40 (0
Current smokers, % (95% CI) 0.7 (0.4–1.0) 4 (2–5)
Diabetes, % (95% CI) 1.3 (0.8–1.7) 6 (4–7)
Mean cognitive score (AH4-I) (SE) 43.7 (0.3) 42.0 (0
No mobility limitation, % (95% CI)b 54 (48–60) 49 (46–
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure.
a p-Values computed using linear regression or analysis of covariance adjusted for age and se
as explanatory variables. Age- and sex-adjusted means (SE) and percentages (95% CI) are pres
b Deﬁned as no self-reported difﬁculty to climb several ﬂights of stairs and to walk more
1997–1999, and 2002–2004.Supplementary Tables 3–7 describe associations between partici-
pants' characteristics, including FRS components, andmotor tests. Asso-
ciations between FRS and walking speed, chair rises, and balance were
explained by a single covariate; note that the weaker association be-
tween low total cholesterol and slow walking speed disappeared
(p = 0.19) after adjustment for HDL-cholesterol. Finger tapping and
grip strength were not associated with most FRS components.
Adjustment for cognitive status in 2007–2009 had little inﬂuence
(supplementary Fig. 1, panel a). After adjustment for SES, BMI, and
height, the association between FRS and motor tests decreased but
remained statistically signiﬁcant, except for balance in 2007–2009
(supplementary Fig. 1, panel b); analyses using time-dependent covar-
iates yielded similar conclusions (data not shown). After exclusion ofsk score
% 15–19.9% ≥20% pa
63 N = 969 N = 1551
28) 10 (8–12) 6 (5–7) b10−3
.2) 67.2 (0.2) 69.7 (0.2) b10−3
53) 49 (45–53) 41 (38–43) b10−3
.1) 28.0 (0.1) 29.1 (0.1) b10−3
0.2) 168.3 (0.2) 167.3 (0.2) b10−3
0.4) 132.0 (0.5) 140.4 (0.4) b10−3
.3) 75.1 (0.3) 78.5 (0.3) b10−3
28) 37 (33–41) 50 (46–55) b10−3
.01) 1.57 (0.01) 1.38 (0.01) b10−3
.03) 5.66 (0.04) 5.86 (0.03) b10−3
9 (5–12) 20 (16–25) b10−3
12 (9–16) 31 (27–36) b10−3
.3) 41.9 (0.4) 41.0 (0.3) b10−3
52) 45 (42–49) 41 (36–45) b10−3
xwith the log-transformed FRS as the dependent variable and participants' characteristics
ented.
than 1 mile before the motor assessment according to questionnaires from 1991–1993,
Table 3
Geometric mean of the Framingham general cardiovascular risk score (1991–1993, 1997–1999, 2002–2004, 2007–2009) by categories of motor function, assessed in 2007–9.
Test of motor function Age- and sex-speciﬁc quartile Framingham general cardiovascular risk score (%)
1991–1993 1997–1999 2002–2004 2007–2009
Geo. mean 95% CI Geo. mean 95% CI Geo. mean 95% CI Geo. mean 95% CI
Walking speed (m/s) Q4 6.5 6.3; 6.8 9.0 8.6; 9.3 11.8 11.4; 12.3 13.6 12.7; 13.6
Q3 6.6 6.4; 6.9 9.1 8.7; 9.4 11.8 11.3; 12.3 14.0 13.0; 14.0
Q2 6.8 6.6; 7.1 9.2 8.8; 9.6 12.5 12.0; 13.0 14.6 13.6; 14.6
Q1 7.2 6.9; 7.5 9.8 9.4; 10.2 13.1 12.6; 13.6 15.6 14.5; 15.6
Difference (Q1–Q4) 0.7 – 0.8 – 1.3 – 2.0 –
Five chair rises (time in seconds for 5 chair rises) Q4 6.5 6.2; 6.8 8.7 8.4; 9.1 11.6 11.1; 12.0 13.9 12.9; 13.9
Q3 6.7 6.4; 7.0 9.2 8.8; 9.6 12.3 11.8; 12.8 14.6 13.6; 14.6
Q2 6.8 6.6; 7.1 9.2 8.8; 9.6 12.4 11.9; 12.9 14.5 13.5; 14.5
Q1 7.1 6.8; 7.4 9.5 9.1; 10.0 12.7 12.2; 13.2 14.7 13.6; 14.7
Difference (Q1–Q4) 0.6 – 0.8 – 1.1 – 0.8 –
Balance test Passed 6.1 6.0; 6.3 8.4 8.2; 8.6 11.2 10.9; 11.5 13.5 12.9; 13.5
Failed 7.7 7.5; 7.9 10.4 10.0; 10.7 13.7 13.3; 14.1 15.3 14.5; 15.3
Difference (failed–passed) 1.6 – 2.0 – 2.5 – 1.8 –
Finger tapping test (number of taps per 10 s) Q4 6.7 6.5; 7.0 9.1 8.7; 9.5 12.1 11.6; 12.5 14.1 13.1; 14.1
Q3 6.8 6.6; 7.1 9.4 9.0; 9.8 12.4 11.9; 12.8 14.6 13.6; 14.6
Q2 6.8 6.6; 7.1 9.1 8.7; 9.5 12.3 11.9; 12.8 14.4 13.4; 14.4
Q1 6.8 6.6; 7.1 9.4 9.0; 9.8 12.4 11.9; 12.9 14.7 13.7; 14.7
Difference (Q1–Q4) 0.1 – 0.3 – 0.4 – 0.7 –
Grip strength (kg) Q4 6.8 6.6; 7.1 9.4 9.0; 9.7 12.3 11.9; 12.8 14.3 13.4; 14.3
Q3 6.6 6.3; 6.9 9.1 8.7; 9.5 12.3 11.8; 12.8 14.2 13.2; 14.2
Q2 7.0 6.7; 7.3 9.3 8.9; 9.8 12.5 12.0; 13.0 14.8 13.8; 14.8
Q1 6.8 6.5; 7.1 9.1 8.7; 9.6 12.1 11.6; 12.6 14.5 13.5; 14.5
Difference (Q1–Q4) 0.0 – −0.2 – −0.2 – 0.2 –
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statistically signiﬁcant in 1991–1993 for walking speed and balance
(supplementary Fig. 1, panel c). There were no sex- (p-values N 0.10)
or age-related differences (p-values N 0.10) in cross-sectional associa-
tions between motor tests and FRS.
4. Discussion
Higher Framingham cardiovascular risk was associated with worse
motor function assessed through measures of walking speed, chair
rises, and balance. Based on repeated FRS assessments, higher risk was
associated with worse motor function 16 years later. This association
was robust to adjustments for BMI, height, SES, and cognitive function;
it was not explained by mobility limitations before motor assessment.
Our ﬁndings suggest that exposure to vascular risk factors in midlife is
associated with poor motor function at older ages. The corollary, that
low vascular risk inmidlifemay delay loss ofmotor function and extend
independent living in the elderly, could become a key clinical and public
health perspective across rapidly aging societies.
It is well recognized that cerebralmulti-infarct states can lead to gait
disorders, but the contribution of vascular risk factors to age-related
changes in motor function has received little research attention. Our
ﬁndings show that high vascular risk is associated with poorer motor
function. This is in agreement with previous studies, mainly based on
walking speed, that reported associations of worse motor function
with individual vascular risk factors (hypertension [5,24], diabetes [6],
homocysteine [25–27], low HDL-cholesterol [28]) or markers of vascu-
lar aging (increased common carotid artery intima–media thickness
[7,8], arterial stiffness [9]). Most prior studies were cross-sectional or
based on a singlemeasure of vascular risk, while we assessed cardiovas-
cular risk four times over many years, thus minimizing the risk of mea-
surement error and reverse causation. To our knowledge, our study is
the ﬁrst investigation of FRS in relation to motor function. This score is
widely used in clinical practice andhas the advantage of integrating sev-
eral risk factors.
Several mechanisms may account for the association between vas-
cular risk factors and poor motor function. First, vascular risk factors
are associated with an increased risk of cardio- and cerebrovascular
events which lead to poor motor function. We excluded participantswith overt vascular disease and our ﬁndings cannot be explained by
such events. It is possible, however, that vascular health contributes to
this association given the link between vascular outcomes such as pe-
ripheral artery disease [29] and heart failure [30] and physical function-
ing. Second, vascular risk factors are associatedwith an increased risk of
whitematter lesions, amarker of vascular brain injury assessed through
brain MRI. Higher volumes of white matter lesions, particularly in the
periventricular region, are associated with poor motor function, proba-
bly by disrupting brain circuits involved in motor control [31,32], and
represent a ‘central’ vascular component. Third, vascular risk factors
are associated with worse cognitive performances [1], which are them-
selves associated with motor function [22,23]. However, our results
remained unchanged in analyses adjusted for a cognitive test associated
with FRS in our study [13]; the association between cardiovascular risk
and motor function was not explained by cognitive status.
There was some heterogeneity across motor tests. The association
with FRS was strongest for walking speed and balance, less pronounced
for chair rises, and absent for ﬁnger tapping and grip strength. These dif-
ferences likely reﬂect the fact that walking speed, balance, and chair
rises represent general measures of motor function, since they involve
several systems and functions, including cardiovascular function,
whileﬁnger tapping and grip strength pertain tomore speciﬁc functions
(psychomotor speed,muscle function). Another potential explanation is
that vascular risk factors increase the risk of peripheral neuropathy in
diabetic patients [33], which could explain the apparent sparing of
upper limbs; however, analyses excludingdiabetic patients yielded sim-
ilar conclusions.
The absolute difference in cardiovascular risk between quartiles
of motor function is modest. For instance, for walking speed, the ab-
solute difference in the 2007–2009 FRS between the worse and best
performers was 2.0%. However, the difference in walking speed be-
tween the top and bottom quartiles is large (~0.6–0.7 m/s). A meta-
analysis estimated that 0.1 m/s higher walking speed was associated
with a 12% reduced risk of mortality [4]; therefore, a 0.6 m/s difference
corresponds to a roughly 50% reduced risk of death and is clinically
relevant as it would signiﬁcantly impact cardiovascular mortality
[34,35].
Previous studies that examined a vascular contribution to motor
performances were performed in elderly subjects. Selection biases
Table 4
Trajectories of the log-transformed Framingham general cardiovascular risk score (FRS) from 1991–1993 to 2007–2009 according to quartiles of tests of motor function (MT) ass sed in 2007–2009.
Parameter Walking speed (N = 5336) (m/s) Five chair rises (N = 4958)
(time in seconds)
Balance test (N = 5268)
(failed vs passed)
Finger tapping test ( = 5348)
(number of taps per 0 s)
Grip strength (N = 5319) (kg)
Beta 95% CI pb Beta 95% CI pb Betac 95% CI p Beta 95% CI pb Beta 95% CI pb
Intercept −2.022 −2.056;−1.987 b10−4 −2.007 −2.043;−1.971 b10−4 −1.769 −1.788;−1.751 b10−4 −1.986 −2.020 1.952 b10−4 −1.969 −2.003;−1.935 b10−4
MT-Q4a 0.000 (Reference) 0.000 (Reference) 0.000 (Reference) 0.000 (Referen ) 0.000 (Reference)
MT-Q3 0.027 −0.022; 0.076 0.056 0.006; 0.107 0.083 0.056; 0.110 b10−4 0.037 −0.012 .086 −0.005 −0.054; 0.044
MT-Q2 0.074 0.025; 0.123 0.054 0.003; 0.105 0.025 −0.023 .074 0.032 −0.016; 0.081
MT-Q1 0.139 0.090; 0.188 b10−4 0.062 0.011; 0.113 0.013 0.040 −0.01; 89 0.16 0.013 −0.037; 0.063 0.38
Time 0.200 0.153; 0.247 b10−4 0.316 0.267; 0.365 b10−4 0.344 0.310; 0.378 b10−4 0.268 0.221; 0 15 b10−4 0.254 0.208; 0.300 b10−4
Time2 −0.143 −0.169;−0.117 b10−4 −0.077 −0.104;−0.050 b10−4 −0.067 −0.086;−0.049 b10−4 −0.106 −0.131 0.08 b10−4 −0.112 −0.137;−0.086 b10−4
Time × MT-Q4 0.000 (Reference) 0.000 (Reference) 0.000 (Reference) 0.000 (Referen ) 0.000 (Reference)
Time × MT-Q3 0.081 0.014; 0.148 −0.054 −0.124; 0.015 −0.047 −0.098; 0.003 0.004 −0.063 .072 −0.013 −0.079; 0.054
Time × MT-Q2 0.066 −0.002; 0.133 −0.056 −0.126; 0.014 −0.032 −0.099 .035 0.024 −0.043; 0.091
Time × MT-Q1 0.076 0.008; 0.144 −0.103 −0.172;−0.033 −0.015 −0.082 .053 0.010 −0.058; 0.079
Time2 × MT-Q4 0.000 (Reference) 0.000 (Reference) 0.000 (Reference) 0.000 (Referen ) 0.000 (Reference)
Time2 × MT-Q3 0.045 0.008; 0.081 −0.043 −0.081;−0.005 −0.024 −0.052; 0.004 0.18 0.001 −0.036 .037 −0.020 −0.057; 0.016
Time2 × MT-Q2 0.027 −0.009; 0.064 −0.038 −0.076; 0.000 −0.022 −0.059 .014 0.012 −0.025; 0.048
Time2 × MT-Q1 0.039 0.001; 0.076 0.095 −0.058 −0.096;−0.020 0.020 −0.013 −0.050 .024 0.47 0.002 −0.035; 0.039 0.85
Trajectories of the log-transformed FRSweremodeled using linearmixedmodelswith randomeffects for the intercept and time (linear, squared) and a backwards time scale. Them effects of the quartiles of themotor tests represent the difference
in the log-transformed FRS between each quartile and the reference quartile in 2007–2009, and the interactions of the quartiles of the motor tests with time and time squared ex ine whether trajectories of the FRS are different in each quartile
compared to the reference quartile. Regression coefﬁcients (beta) were back transformed to present these ﬁndings graphically (Fig. 1).
a MT-Q1 to -Q4: age- and sex-speciﬁc quartiles of motor tests from worse (Q1) to better function (Q4, reference); for the balance test, Q4 corresponds to those who passed the est and Q3 to those who failed the test.
b p-Values for trend for themain effect of the quartiles of themotor tests and for their interactionswith time (linear, squared) computed by including a four-level ordinal variable ﬁned by themean of the tests in each of the quartiles.We report a
global test for the interactions of motor tests with time (linear, squared).
c The linearmixedmodelwas adjusted for age (centered at 65 years; p b 10−4) and sex (reference group,males; p b 10−4), the interactions of age and sexwith time and time square (all p b 10−4), the interaction between age and sex (p b 10−4), and
the three-way interaction between age, sex, and time (p = 0.002).
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Fig. 1. Predicted trajectories of the Framingham general cardiovascular risk score from 1991–1993 to 2007–2009 by quartiles of motor tests assessed in 2007–2009. Graphs are based on
the back transformation of the log-FRS predicted by linearmixedmodels (Table 4). Quartiles ofwalking speed, chair rises,ﬁnger tapping, and grip strengthwere deﬁned based on age- and
sex-speciﬁc distributions (supplementary Table 2): Q4 (best function), dotted line; Q3, short-dashed line; Q2, long-dashed line; Q1 (worst function), solid line. For balance (c): passed,
dotted line; failed, solid line; this graph corresponds to men aged 65 years in 2007–2009. Numbers on top of curves represent FRS differences between Q4 and Q1 (or between those
who passed and failed the balance test) 16, 10, 5, and 0 years before motor function was assessed (*p b 0.05, †p b 10−3).
101A. Elbaz et al. / International Journal of Cardiology 172 (2014) 96–102related to competing risks of death as well as reverse causation may
complicate their interpretation. Our analyses, in contrast, are based on
subjectswhowere on average ~49 years old at baseline followed for ap-
proximately 16 years; one important ﬁnding is that differences in FRS
across groups deﬁned by motor tests were already established many
years before the motor assessment and well before the start of old
age. However, themain limitation of our analyses is thatmotor function
was measured once, and we were not able to study the association be-
tween the FRS and change inmotor function. This limits causal inference
as we were not able to formally assess temporality and to examine
when differences in motor function appeared among participants;
results of analyses with exclusion of persons who developed mobility
limitations are reassuring to this respect. Our analyses are based on par-
ticipants who participated in 2007–2009, which raises that possibility
that selection biases due to survival or other causes may impact our
ﬁndings. This is however unlikely given that the association between
the FRS and motor tests was not modiﬁed by age; because persons
who did not participate in 2007–2009 had higher FRS in 1991–1993
and are likely to be in worse health and have worse motor function
[36], our estimates of the association between motor function and FRS
are likely to be conservative. Finally, Whitehall II participants are
ofﬁce-based civil servants and not fully representative of the British
population, which may limit the generalizability of our ﬁndings; this is
likely, however, to mainly affect the distribution of risk rather than the
strength of associations.
Our study has several strengths, including its large size and extended
follow-up with at least three FRS measures available for most partici-
pants, thus allowing modeling trajectories over time. The availability
of tests assessingdifferent aspects ofmotor function is also an important
feature.In conclusion, our ﬁndings are in line with research on cognitive
function anddementia showing that higher vascular risk inmidlife is as-
sociated with worse outcomes later in life [2]. Our study is the ﬁrst to
show that participants with poormotor function have higher cardiovas-
cular risk and that this association was already present approximately
16 years before the assessment of motor function. These ﬁndings sug-
gest that vascular risk factors play an important and under-recognized
role in motor function, independently of their impact on cognition.
Thus, better control of vascular risk factors inmidlifemay prevent phys-
ical impairment and disability in the elderly.
Funding
ASM is supported by a “European Young Investigator Award” from
the European Science Foundation. EJB andMS are supported by the Brit-
ish Heart Foundation. MK is supported by the BUPA Foundation, UK, the
Academy of Finland, Finland, and an ESRC professorship. TheWhitehall
II study has been supported by grants from the BritishMedical Research
Council (MRC); the British Heart Foundation; the British Health and
Safety Executive; the British Department of Health; the National
Heart, Lung, and Blood Institute (R01HL036310); and theNational Insti-
tute on Aging (R01AG013196 and R01AG034454). The funders had no
role in the design or conduct of the study, in the collection, analysis
and interpretation of data, in the preparation or approval of the manu-
script, and in the decision to submit it to publication.
Acknowledgments
We thank all participating civil service departments and their wel-
fare, personnel, and establishment ofﬁcers; the British Occupational
102 A. Elbaz et al. / International Journal of Cardiology 172 (2014) 96–102Health and Safety Agency; the British Council of Civil Service Unions; all
participating civil servants; and all members of the Whitehall II study
team. The Whitehall II study team comprises research scientists, statis-
ticians, study coordinators, nurses, data managers, administrative assis-
tants and data entry staff, who make the study possible.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ijcard.2013.12.051.
References
[1] Warsch JR, Wright CB. The aging mind: vascular health in normal cognitive aging. J
Am Geriatr Soc 2010;58(Suppl. 2):S319–24.
[2] Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment
and dementia: a statement for healthcare professionals from the American Heart As-
sociation/American Stroke Association. Stroke 2011;42:2672–713.
[3] den Ouden ME, Schuurmans MJ, Arts IE, van der Schouw YT. Physical performance
characteristics related to disability in older persons: a systematic review. Maturitas
2011;69:208–19.
[4] Studenski S, Perera S, Patel K, et al. Gait speed and survival in older adults. JAMA
2011;305:50–8.
[5] Dumurgier J, Elbaz A, Dufouil C, Tavernier B, Tzourio C. Hypertension and lower
walking speed in the elderly: the Three-City study. J Hypertens 2009;28:1506–14.
[6] Ko SU, Stenholm S, Chia CW, Simonsick EM, Ferrucci L. Gait pattern alterations in older
adults associated with type 2 diabetes in the absence of peripheral neuropathy—results
from the Baltimore Longitudinal Study of Aging. Gait Posture 2011;34:548–52.
[7] Elbaz A, Ripert M, Tavernier B, et al. Common carotid artery intima–media thickness,
carotid plaques, and walking speed. Stroke 2005;36:2198–202.
[8] Hamer M, Kivimaki M, Lahiri A, et al. Walking speed and subclinical atherosclerosis
in healthy older adults: the Whitehall II study. Heart 2010;96:380–4.
[9] Brunner EJ, Shipley MJ, Witte DR, et al. Arterial stiffness, physical function, and func-
tional limitation: the Whitehall II study. Hypertension 2011;57:1003–9.
[10] Lloyd-Jones DM. Cardiovascular risk prediction: basic concepts, current status, and
future directions. Circulation 2010;121:1768–77.
[11] Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J. Risk
score for the prediction of dementia risk in 20 years among middle aged people: a
longitudinal, population-based study. Lancet Neurol 2006;5:735–41.
[12] Elias MF, Sullivan LM, D'Agostino RB, et al. Framingham stroke risk proﬁle and
lowered cognitive performance. Stroke 2004;35:404–9.
[13] Kaffashian S, Dugravot A, Nabi H, et al. Predictive utility of the Framingham general
cardiovascular disease risk proﬁle for cognitive function: evidence from the White-
hall II study. Eur Heart J 2011;32:2326–32.
[14] D'Agostino Sr RB, Vasan RS, Pencina MJ, et al. General cardiovascular risk proﬁle for
use in primary care: the Framingham Heart Study. Circulation 2008;117:743–53.
[15] Marmot MG, Smith GD, Stansfeld S, et al. Health inequalities among British civil ser-
vants: the Whitehall II study. Lancet 1991;337:1387–93.
[16] Dilks L, Marceaux L, Mayeaux B, Turner D, Bourassa J, Bourgeois M. Validity study
of the Western psychological services ﬁnger-tapping test. Am J Psychol Res
2006;2:8–13.[17] Expert committee on the diagnosis and classiﬁcation of diabetes mellitus. Report of
the expert committee on the diagnosis and classiﬁcation of diabetes mellitus. Diabe-
tes Care 2003;26(Suppl. 1):S5–S20.
[18] Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A.
Myocardial infarction and coronary deaths in the World Health Organization
MONICA Project. Registration procedures, event rates, and case-fatality rates in 38
populations from 21 countries in four continents. Circulation 1994;90:583–612.
[19] Heim AW. AH 4 group test of general intelligence. Windsor, UK: NFER-Nelson Pub-
lishing Company Ltd.; 1970.
[20] Cooper R, Hardy R, Aihie SA, et al. Age and gender differences in physical capability
levels from mid-life onwards: the harmonisation and meta-analysis of data from
eight UK cohort studies. PLoS One 2011;6:e27899.
[21] Brunner E, Shipley M, Spencer V, et al. Social inequality in walking speed in early old
age in the Whitehall II study. J Gerontol A Biol Sci Med Sci 2009;64:1082–9.
[22] Soumaré A, Tavernier B, Alpérovitch A, Tzourio C, Elbaz A. A cross-sectional and lon-
gitudinal study of the relation between walking speed and cognitive function in
community-dwelling elderly people. J Gerontol A Biol Sci Med Sci 2009;64:1058–65.
[23] Rosano C, Simonsick EM, Harris TB, et al. Association between physical and cognitive
function in healthy elderly: the health, aging and body composition study.
Neuroepidemiology 2005;24:8–14.
[24] Rosano C, Longstreth Jr WT, Boudreau R, et al. High blood pressure accelerates gait
slowing in well-functioning older adults over 18-years of follow-up. J Am Geriatr
Soc 2011;59:390–7.
[25] Kado DM, Bucur A, Selhub J, Rowe JW, Seeman T. Homocysteine levels and de-
cline in physical function: MacArthur Studies of Successful Aging. Am J Med
2002;113:537–42.
[26] Soumaré A, Elbaz A, Ducros V, Tavernier B, Alpérovitch A, Tzourio C. Homocysteine
and motor function in the elderly. Neurology 2006;67:985–90.
[27] Kuo HK, Liao KC, Leveille SG, et al. Relationship of homocysteine levels to quadriceps
strength, gait speed, and late-life disability in older adults. J Gerontol A Biol Sci Med
Sci 2007;62:434–9.
[28] Volpato S, Ble A, Metter EJ, et al. High-density lipoprotein cholesterol and objective
measures of lower extremity performance in older nondisabled persons: the
InChianti study. J Am Geriatr Soc 2008;56:621–9.
[29] Brach JS, Solomon C, Naydeck BL, et al. Incident physical disability in people with
lower extremity peripheral arterial disease: the role of cardiovascular disease. J
Am Geriatr Soc 2008;56:1037–44.
[30] Inzitari M, Carlo A, Baldereschi M, et al. Risk and predictors of motor-performance
decline in a normally functioning population-based sample of elderly subjects: the
Italian Longitudinal Study on Aging. J Am Geriatr Soc 2006;54:318–24.
[31] Soumaré A, Elbaz A, Zhu Y, et al. White matter lesions volume and motor perfor-
mances in the elderly. Ann Neurol 2009;65:706–15.
[32] Zheng JJ, Delbaere K, Close JC, Sachdev PS, Lord SR. Impact of whitematter lesions on
physical functioning and fall risk in older people: a systematic review. Stroke
2011;42:2086–90.
[33] Tesfaye S, Chaturvedi N, Eaton SE, et al. Vascular risk factors and diabetic neuropa-
thy. N Engl J Med 2005;352:341–50.
[34] Dumurgier J, Elbaz A, Ducimetiere P, Tavernier B, Alperovitch A, Tzourio C. Slow
walking speed and cardiovascular death in well functioning older adults: prospec-
tive cohort study. BMJ 2009;339:b4460.
[35] Elbaz A, Sabia S, Brunner E, et al. Association of walking speed in late midlife with
overall and cause-speciﬁc mortality: results from the Whitehall II cohort study.
Age 2012;35(3):943–52.
[36] Ferrie JE, Kivimaki M, Singh-Manoux A, et al. Non-response to baseline, non-
response to follow-up and mortality in the Whitehall II cohort. Int J Epidemiol
2009;38:831–7.
